Kurs
-5,50%
Likviditet
0,00 MSEK
Kalender
Tid* | ||
2026-02-20 | N/A | Bokslutskommuniké 2025 |
2025-11-14 | N/A | Kvartalsrapport 2025-Q3 |
2025-08-22 | N/A | Kvartalsrapport 2025-Q2 |
2025-05-16 | N/A | Kvartalsrapport 2025-Q1 |
2025-02-14 | N/A | Bokslutskommuniké 2024 |
2024-11-22 | - | Kvartalsrapport 2024-Q3 |
2024-09-26 | - | Split PERP B 24:1 |
2024-08-30 | - | Extra Bolagsstämma 2024 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-06-17 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2024-06-14 | - | Årsstämma |
2024-05-17 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2023-11-17 | - | Kvartalsrapport 2023-Q3 |
2023-11-15 | - | Extra Bolagsstämma 2023 |
2023-08-25 | - | Kvartalsrapport 2023-Q2 |
2023-06-20 | - | Årsstämma |
2023-05-17 | - | Kvartalsrapport 2023-Q1 |
2023-05-05 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2023-02-17 | - | Bokslutskommuniké 2022 |
2022-11-18 | - | Kvartalsrapport 2022-Q3 |
2022-08-25 | - | Kvartalsrapport 2022-Q2 |
2022-05-24 | - | Årsstämma |
2022-05-20 | - | Kvartalsrapport 2022-Q1 |
2022-05-09 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2022-02-25 | - | Bokslutskommuniké 2021 |
2021-11-19 | - | Kvartalsrapport 2021-Q3 |
2021-08-27 | - | Kvartalsrapport 2021-Q2 |
2021-05-25 | - | Kvartalsrapport 2021-Q1 |
2021-05-04 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2021-03-23 | - | Extra Bolagsstämma 2021 |
2021-02-12 | - | Bokslutskommuniké 2020 |
2020-11-24 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-06-16 | - | Extra Bolagsstämma 2020 |
2020-05-13 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2020-04-23 | - | Kvartalsrapport 2020-Q1 |
2020-02-13 | - | Bokslutskommuniké 2019 |
2019-11-21 | - | Kvartalsrapport 2019-Q3 |
2019-08-29 | - | Kvartalsrapport 2019-Q2 |
2019-04-30 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2019-04-29 | - | Årsstämma |
2019-04-26 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-11-21 | - | Kvartalsrapport 2018-Q3 |
2018-08-29 | - | Kvartalsrapport 2018-Q2 |
2018-05-04 | - | Split PERP B 2:1 |
2018-05-03 | - | Kvartalsrapport 2018-Q1 |
2018-04-25 | - | Extra Bolagsstämma 2018 |
2018-03-16 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2018-03-15 | - | Årsstämma |
2018-02-14 | - | Bokslutskommuniké 2017 |
2017-11-15 | - | Kvartalsrapport 2017-Q3 |
2017-08-29 | - | Kvartalsrapport 2017-Q2 |
2017-05-04 | - | X-dag ordinarie utdelning PERP B 0.00 SEK |
2017-05-03 | - | Årsstämma |
2017-05-03 | - | Kvartalsrapport 2017-Q1 |
2017-02-16 | - | Bokslutskommuniké 2016 |
2017-01-11 | - | Extra Bolagsstämma 2017 |
2016-11-25 | - | Kvartalsrapport 2016-Q3 |
2016-08-24 | - | Kvartalsrapport 2016-Q2 |
2016-04-25 | - | Årsstämma |
2016-04-25 | - | Kvartalsrapport 2016-Q1 |
2016-02-17 | - | Bokslutskommuniké 2015 |
2015-11-19 | - | Kvartalsrapport 2015-Q3 |
2015-08-26 | - | Kvartalsrapport 2015-Q2 |
2015-05-21 | - | Kvartalsrapport 2015-Q1 |
2015-03-26 | - | Årsstämma |
2015-03-05 | - | Bokslutskommuniké 2014 |
Beskrivning
Land | Sverige |
---|---|
Lista | First North Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the "Company"), took place today, Wednesday, April 16, 2024, at 11.00 am at Clarion Hotell Gillet in Uppsala.
All decisions were made in accordance with the Board's previously published proposal and with the required majority.
Decisions new articles of association for the company
It was resolved to change § 1 Company name in the articles of association to: "The company's company name is Perpetua Medical AB (publ). The company is public." In the event that the company name, for any reason, is not approved by the Swedish Companies Registration Office, the following alternative company names names in, the order indicated, will be reviewed: Perpetua Life AB (publ), Perpetua Group AB (publ) and Perpetua Holdings AB (publ).
It was resolved to change § 3 Operations in the articles of association to: "The company shall, through wholly- and partly-owned subsidiaries, develop, manufacture, market and sell products and solutions within the healthcare sector, and engage in other activities compatible therewith."
Erik Hedlund, Chairman
Email: erik.hedlund@nolsterbyinvest.se
Phone: +46 70-382 08 41